Cargando…
Advances in genetic therapeutic strategies for Duchenne muscular dystrophy
NEW FINDINGS: What is the topic of this review? This review highlights recent progress in genetically based therapies targeting the primary defect of Duchenne muscular dystrophy. What advances does it highlight? Over the last two decades, considerable progress has been made in understanding the mech...
Autores principales: | Guiraud, Simon, Chen, Huijia, Burns, David T., Davies, Kay E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973818/ https://www.ncbi.nlm.nih.gov/pubmed/26140505 http://dx.doi.org/10.1113/EP085308 |
Ejemplares similares
-
Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019) -
Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
por: Goyenvalle, Aurélie, et al.
Publicado: (2011) -
Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
por: Sun, Chengmei, et al.
Publicado: (2020) -
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019) -
Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy
por: Himič, Vratko, et al.
Publicado: (2021)